z-logo
Premium
Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon‐α in 1 st trimester: Report of 3 cases and review of the literature
Author(s) -
Mubarak A.A.S.,
Kakil I.R.,
Awidi A.,
AlHomsi U.,
Fawzi Z.,
Kelta M.,
AlHassan A.
Publication year - 2002
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.9876
Subject(s) - medicine , myeloid leukemia , pregnancy , alpha interferon , pediatrics , leukemia , first trimester , myeloid , obstetrics , interferon , gestation , immunology , genetics , biology
Three patients with Chronic Myeloid Leukemia (CML) in chronic phase received Interferon‐α during pregnancy, starting from the 1 st trimester. No maternal complications were reported. The 3 patients delivered normal looking babies apart from one baby who was found to have transient mild thrombocytopenia. Subsequently these children were followed for 30, 12, and 4 months and all had normal growth and development. Am. J. Hematol. 69:115–118, 2002. © 2002 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom